Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Transplant International : Official Journal of the European Society for Organ Transplantation|July 24, 2012
Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II studyJosep Grinyo, Josefina Alberu, Fabiana L C Contieri, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 6, 2010
Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II studyLionel Rostaing, Pablo Massari, Valter Duro Garcia, et al.
BMJ Open|October 8, 2021
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept studyOlivier Aubert, Gillian Divard, Julio Pascual, et al.
Clinical Transplantation|January 29, 2019
Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantationEfrat Harel, Jun Shoji, Vivek Abraham, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 15, 2006
Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipientsFlavio Vincenti, Amado de Andrés, Thomas Becker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 11, 2018
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donorFlavio Vincenti, Klemens Budde, Pierre Merville, et al.
Science Translational Medicine|March 20, 2020
A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejectionJoshua Y C Yang, Reuben D Sarwal, Tara K Sigdel, et al.
Transplantation|January 16, 2004
Retransplantation in patients with graft loss caused by polyoma virus nephropathyEmilio Ramos, Flavio Vincenti, Wei X Lu, et al.
The New England Journal of Medicine|August 27, 2005
Costimulation blockade with belatacept in renal transplantationFlavio Vincenti, Christian Larsen, Antoine Durrbach, et al.
Transplantation Direct|May 21, 2024
Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST RegistryChristian P Larsen, Flavio Vincenti, Tzuyung D Kou, et al.
Pageof 13